Green Sands Equity is a boutique private equity investment firm established in 2015 and located in San Francisco, California. The firm specializes in growth capital, investment advisory, and strategic buyouts, focusing on long-term investments in portfolio companies. Green Sands Equity primarily targets sectors such as space, technology, healthcare, and future technologies. Additionally, the firm offers expertise in political and policy strategy, facilitating connections between the private sector and government entities.
Axyon AI SRL is a fintech company based in Modena, Italy, with an additional office in London, UK, focused on developing artificial intelligence-based web applications for the banking and investment management sectors. Founded in 2016, the company offers products such as Axyon SynFinance, which provides predictive analytics for liquidity analysis and market trends, and Axyon IRIS, which delivers forecasts on key financial metrics like volatility and performance ratios. By leveraging deep learning technologies, Axyon AI creates customized predictive models tailored to specific assets and investment strategies, enhancing decision-making and portfolio management for asset managers. The company's innovations aim to improve alpha generation and streamline risk management processes within capital markets.
Stepful
Series B in 2024
Stepful is a training platform designed to assist individuals without college degrees in entering the healthcare job market. The company offers a comprehensive curriculum that includes online instructor-led classes, electronic textbooks, practice quizzes, and flashcards. Additionally, Stepful provides in-person clinical sessions to develop hands-on skills, particularly in bloodwork. To further support its users, the platform also includes job placement assistance, helping graduates secure entry-level positions in the healthcare industry and facilitating opportunities for career advancement. By focusing on high school graduates, Stepful aims to fill vacancies in the healthcare sector quickly while reducing hiring costs for employers.
Axyon AI
Venture Round in 2024
Axyon AI SRL is a fintech company based in Modena, Italy, with an additional office in London, UK, focused on developing artificial intelligence-based web applications for the banking and investment management sectors. Founded in 2016, the company offers products such as Axyon SynFinance, which provides predictive analytics for liquidity analysis and market trends, and Axyon IRIS, which delivers forecasts on key financial metrics like volatility and performance ratios. By leveraging deep learning technologies, Axyon AI creates customized predictive models tailored to specific assets and investment strategies, enhancing decision-making and portfolio management for asset managers. The company's innovations aim to improve alpha generation and streamline risk management processes within capital markets.
TreQ
Seed Round in 2024
TreQ is a manufacturing company that builds and operates bespoke quantum computing clusters.
Ephos
Seed Round in 2024
Ephos specializes in the development of integrated photonic circuits utilizing glass technology to improve computing capabilities. The company aims to minimize signal loss, facilitating innovative designs for both classical and quantum applications. By employing a proprietary manufacturing process, Ephos produces high-quality circuits tailored to the specific requirements of clients in the computational infrastructure sector. Their products are particularly suited for use in quantum computing, quantum communications, and quantum sensing, enabling customers to create scalable quantum infrastructures.
Vectara
Series A in 2024
Vectara is a provider of a generative AI product platform that enables the integration of advanced AI features into various applications. Its offering includes a serverless Retrieval Augmented Generation (RAG) API platform designed to embed generative AI functionality into chatbots and other products, relying on a robust hybrid-search core. This platform ensures accurate and contextually relevant responses, addressing critical challenges for enterprise adoption such as reducing hallucination, enhancing explainability, enforcing access control, and allowing real-time updates of knowledge. Vectara's technology also emphasizes data security and supports multilingual capabilities, making it suitable for a broad range of applications including conversational AI, question-answering, and semantic search. Through its innovative platform, Vectara helps businesses create effective AI-driven experiences while maintaining compliance with intellectual property and bias considerations.
Elve
Series A in 2024
Elve is a manufacturer specializing in high-efficiency millimeter-wave and near-terahertz power amplifiers, aimed at enhancing wireless connectivity. The company develops advanced technologies that facilitate fiber-like wireless internet links through the production of its amplifiers. By integrating agile manufacturing techniques into its vacuum electronic devices, Elve delivers innovative solutions that support widespread connectivity, improving online experiences for users and businesses alike.
Stepful
Series A in 2024
Stepful is a training platform designed to assist individuals without college degrees in entering the healthcare job market. The company offers a comprehensive curriculum that includes online instructor-led classes, electronic textbooks, practice quizzes, and flashcards. Additionally, Stepful provides in-person clinical sessions to develop hands-on skills, particularly in bloodwork. To further support its users, the platform also includes job placement assistance, helping graduates secure entry-level positions in the healthcare industry and facilitating opportunities for career advancement. By focusing on high school graduates, Stepful aims to fill vacancies in the healthcare sector quickly while reducing hiring costs for employers.
Fizz
Series B in 2023
Fizz is an authorized platform designed to enhance community social structures, particularly within institutions. It develops online social media software that facilitates communication and the sharing of ideas, events, and experiences among users. The platform allows individuals to post secret confessions and ask questions within a closed community, promoting social interaction while maintaining anonymity. By leveraging these features, Fizz aims to foster a more connected and engaged community environment.
Sagence AI
Series A in 2023
Analog Inference is a company focused on advancing neural computing through innovative technology. Founded by experienced professionals from the computing industry and supported by Khosla Ventures, the company is developing its first generation of products. It specializes in deep sub-threshold analog in-memory computation, which allows for the execution of complex neural networks at full resolution while maintaining low latency and eliminating the need for active cooling. This technology enables the performance of data-center-grade artificial intelligence workloads with significantly reduced power consumption, facilitating the deployment of server-class networks in more cost-effective devices.
Paradromics
Series A in 2023
Paradromics, Inc. is focused on developing advanced brain-machine interfaces aimed at enhancing communication between the brain and external devices, particularly for individuals with neurodegenerative diseases. The company specializes in creating implantable systems that facilitate neural data decoding, allowing complex brain signals to be translated into data streams suitable for various neural prostheses. Paradromics is dedicated to providing high data-rate brain-computer interface technology that supports bidirectional data transmission, enabling patients to regain functionality lost due to neurological conditions. Founded in 2015, the company is headquartered in Austin, Texas.
PASQAL
Series B in 2023
Pasqal SAS, founded in 2019 and headquartered in Paris, France, specializes in the manufacture of quantum information processors utilizing atomic arrays. The company focuses on developing full-stack quantum computing technology that simulates complex phenomena to facilitate scientific discovery. Its innovative approach employs qubits made of neutral atoms organized in large two-dimensional and three-dimensional arrays, which enables analog computing. This technology addresses a variety of challenges, including optimization, drug discovery, and machine learning, empowering organizations to tackle complex problems across these fields.
Elve
Venture Round in 2023
Elve is a manufacturer specializing in high-efficiency millimeter-wave and near-terahertz power amplifiers, aimed at enhancing wireless connectivity. The company develops advanced technologies that facilitate fiber-like wireless internet links through the production of its amplifiers. By integrating agile manufacturing techniques into its vacuum electronic devices, Elve delivers innovative solutions that support widespread connectivity, improving online experiences for users and businesses alike.
ArsenalBio
Series B in 2022
ArsenalBio is a programmable cell therapy company established in 2019, focused on developing effective and accessible immune cell therapies, primarily targeting cancer treatment. The company utilizes advanced technologies, including CRISPR-based genome engineering, synthetic biology, and machine learning, to create a new paradigm for discovering and developing immune cell therapies. ArsenalBio's innovative approach aims to enhance the efficacy and safety of T-cell therapies while reducing costs for providers and broadening patient access. By employing a full-stack research and development engine, ArsenalBio generates multifunctional T-cell medicines through the precise insertion of large synthetic DNA sequences, enabling clinicians to utilize next-generation autologous T-cell therapies to combat cancer more effectively.
Qenta
Venture Round in 2022
Qenta is a financial technology platform established in 2016 and headquartered in Houston, Texas. The company specializes in cashless payment processing, primarily serving the Austrian and Central European markets. Qenta offers a comprehensive suite of financial services designed for enterprises, financial institutions, and individual users. Its platform integrates advanced solutions that include asset tokenization and innovative blockchain technologies. Additionally, Qenta provides guidance on both offline and online payment methods, addressing security requirements and facilitating risk-free online transactions. By tailoring international payment strategies to specific sales channels, Qenta aims to enhance the payment experience for its diverse clientele.
Stepful
Venture Round in 2022
Stepful is a training platform designed to assist individuals without college degrees in entering the healthcare job market. The company offers a comprehensive curriculum that includes online instructor-led classes, electronic textbooks, practice quizzes, and flashcards. Additionally, Stepful provides in-person clinical sessions to develop hands-on skills, particularly in bloodwork. To further support its users, the platform also includes job placement assistance, helping graduates secure entry-level positions in the healthcare industry and facilitating opportunities for career advancement. By focusing on high school graduates, Stepful aims to fill vacancies in the healthcare sector quickly while reducing hiring costs for employers.
Good Chemistry
Seed Round in 2022
Good Chemistry Company focuses on enhancing health, cleanliness, and sustainability through advanced material design. It has developed a proprietary cloud-based computational chemistry platform called QEMIST Cloud. This platform empowers computational chemistry developers to create chemical simulation applications and workflows by utilizing cutting-edge algorithms in quantum chemistry, machine learning, and quantum computing. By predicting chemical properties with remarkable speed and scale, Good Chemistry contributes significantly to the field of computational chemistry, facilitating innovation and efficiency in material design.
Colossal Laboratories & Biosciences
Series A in 2022
Colossal Laboratories & Biosciences is a bioscience and genetic engineering company dedicated to addressing extinction and biodiversity loss through innovative gene editing technologies, primarily CRISPR. The company focuses on reviving extinct species, such as the woolly mammoth, while also working to protect critically endangered species and restore vital ecosystems. By employing advanced genetic techniques, Colossal aims to create solutions that not only facilitate the repopulation of ecosystems but also contribute to the sustainability of life on Earth. Through its pioneering efforts, Colossal aspires to tackle pressing environmental challenges and support the future of both ecological health and human necessities.
Devoted
Series D in 2021
Devoted Health is a healthcare company focused on enhancing the health and well-being of older Americans by treating each individual with care and compassion. The company offers an integrated healthcare solution that includes Medicare Advantage plans, access to local providers, and the option for virtual and in-home care through Devoted Medical. Their approach includes personalized medical plans and dedicated guides who work closely with physicians to streamline care and minimize unnecessary procedures. By leveraging advanced technology and a robust network of healthcare professionals, Devoted Health aims to provide high-quality, tailored healthcare services to its members.
USA Rare Earth
Venture Round in 2021
USA Rare Earth LLC is engaged in the exploration and processing of critical minerals, specializing in rare earth elements, lithium, high-tech metals, uranium, and beryllium. Founded in 2019 and based in New York, the company operates the Round Top Heavy Rare Earth, Lithium and Critical Minerals Project, in which it holds an 80% interest. The Round Top project is notable for its diverse array of heavy rare earth elements and is anticipated to be among the lowest-cost producers of rare earths and lithium globally. By supplying these essential materials, USA Rare Earth aims to support industries such as defense and consumer electronics, contributing to advancements in energy, mobility, and national security.
Commure
Series D in 2021
Commure, Inc. is an innovative company that has developed an open platform aimed at healthcare software developers. Founded in 2017 and headquartered in San Francisco, California, with additional offices in Boston, Montreal, and Bogota, Commure provides a comprehensive developer platform that facilitates the creation and deployment of next-generation healthcare applications. This platform is built on the open HL7 FHIR standard, offering essential features such as an FHIR API server, security framework, event service bus, EHR integration, and more. By unifying disparate datasets and delivering meaningful insights, Commure enhances performance and fosters collaboration among doctors, nurses, and patients, ultimately empowering the healthcare ecosystem to improve care delivery. The company's commitment to interoperability and innovation positions it as a leader in the healthcare technology space.
Noble Money
Seed Round in 2021
Noble Money is a digital currency company focused on making sound money accessible to everyone. The company aims to promote the adoption of digital currencies, beginning with governmental integration. By specializing in digital currency tokenization, Noble Money seeks to enhance the usability and scalability of these currencies, thereby facilitating broader acceptance and implementation in various sectors.
Senti Bio
Series B in 2021
Senti Biosciences is a clinical-stage biotechnology company specializing in synthetic biology and gene circuit engineering for therapeutic purposes. The company employs its Gene Circuits platform to develop innovative therapies that enhance precision in targeting cancer cells while avoiding damage to healthy cells. Senti Bio's approach involves the use of allogeneic chimeric antigen receptor natural killer (CAR-NK) cells that incorporate its gene circuit technologies, aimed at addressing various oncology indications. Among its product candidates are SENTI-202, a Logic Gated off-the-shelf CAR-NK cell therapy designed to selectively eliminate cancer cells without harming healthy bone marrow, and SENTI-301A, which targets hepatocellular carcinoma. Senti Biosciences aims to provide effective treatment options for difficult-to-treat diseases through advanced cell and gene therapies.
AST SpaceMobile
Venture Round in 2021
AST SpaceMobile is a satellite designer and manufacturer headquartered in Midland, Texas, focused on creating the first global broadband cellular network in space. Founded in 2017, the company aims to provide direct connectivity to standard, unmodified mobile devices, addressing the connectivity gaps faced by billions of mobile subscribers worldwide. By leveraging its extensive intellectual property and patent portfolio, AST SpaceMobile is developing a service that offers cost-effective, high-speed cellular broadband to users in areas lacking terrestrial cellular coverage. The company's mission is to connect the unconnected by enabling reliable mobile communication for those who currently lack access to broadband services.
ReViral
Series C in 2020
ReViral Ltd is a biotechnology company based in Stevenage, United Kingdom, that specializes in the discovery and development of antiviral drugs targeting the respiratory syncytial virus (RSV). Founded in 2011, ReViral focuses on creating novel first-in-class compounds, including a highly potent fusion inhibitor designed to treat severe RSV infections, particularly in vulnerable populations such as neonates. The company's innovative approach aims to expand the antiviral market by providing effective treatment options for patients affected by RSV, a virus known for causing significant respiratory illness. Through its research and development efforts, ReViral seeks to address unmet medical needs in the realm of viral infections.
Praxis Precision Medicines
Series C in 2020
Praxis Precision Medicines is a clinical-stage biopharmaceutical company focused on developing therapies for central nervous system disorders marked by neuronal imbalance. Established in 2015 and headquartered in Cambridge, Massachusetts, the company leverages genetic insights to create innovative treatments for neurological and psychiatric conditions. Its leading product candidates include PRAX-114, an allosteric modulator targeting GABAA receptors, currently undergoing Phase IIa trials for major depressive disorder and perimenopausal depression, and PRAX-944, a selective inhibitor of T-type calcium channels in Phase IIa trials for essential tremor. Additionally, Praxis is advancing PRAX-562, a sodium current blocker in Phase I trials for severe pediatric epilepsy and adult cephalgia, along with PRAX-222, an antisense oligonucleotide aimed at treating patients with SCN2A epilepsy, and a program focused on KCNT1-related epilepsy. The company has established collaborations and licensing agreements with various organizations to enhance its research and development efforts.
Encoded Therapeutics
Series D in 2020
Encoded Therapeutics, Inc. is a biotechnology company that specializes in precision gene therapies aimed at treating a wide array of severe genetic disorders. Utilizing a unique platform, Encoded identifies sequences within the human genome that regulate gene expression through advanced screening and computational techniques. The company's therapy pipeline targets both genetic and acquired disorders across various disease pathways, including neurocircuitry, liver and metabolic disorders, neurodegeneration, and cardiovascular diseases. Founded in 2014 and based in South San Francisco, California, Encoded Therapeutics is focused on developing innovative solutions that enable medical practitioners to improve patient outcomes and enhance quality of life.
Didi
Venture Round in 2020
Didi Chuxing, founded in 2012 in Beijing, is a leading mobile transportation platform providing app-based services such as taxi hailing, private car-hailing, social ride-sharing, car rental, and enterprise solutions. With over 450 million users and daily orders reaching 25 million, Didi offers a variety of mobility options to optimize resource allocation through big data-driven algorithms. The company aims to address transportation, environmental, and employment challenges by collaborating with communities and partners. Acquiring Uber China in 2016, Didi has over 21 million drivers and car owners on its platform, generating income while offering convenient transportation solutions to users worldwide.
BedRock Systems
Venture Round in 2020
Our Mission is to BedRock the world’s critical systems from Edge to Server and Cloud implementing the most trusted Provably Unbreakable™ and Programmable Hypervisor platform with Active Security™
Whiterabbit.ai
Venture Round in 2020
Whiterabbit.ai is a company focused on developing artificial intelligence-driven software designed to improve the early detection of cancer, particularly breast cancer. Its platform aims to transform the screening and diagnostic process by addressing key challenges throughout the cancer screening journey. This includes enhancing patient compliance and improving the accuracy of healthcare providers, ultimately leading to better patient outcomes. By leveraging advanced technology, Whiterabbit.ai seeks to engage patients effectively and elevate the overall quality of care in cancer detection.
1QBit
Series B in 2017
1QBit is a quantum computing software company that addresses complex computational challenges by reformulating problems to utilize the capabilities of quantum computing. The company develops software that combines machine intelligence and optimization science on a hardware-agnostic platform, allowing for innovative solutions across various applications. This approach enables clients and hardware providers to enhance their applications by leveraging advancements in both classical and quantum computing technologies.
Lyft
Venture Round in 2017
Lyft is a prominent transportation company that operates a mobile application designed to connect drivers with passengers seeking rides. Established in 2013, Lyft serves as the second-largest ride-sharing service provider in the United States and Canada, offering a range of ride options, including traditional private rides, shared rides, and luxury services. The app not only facilitates ride requests but also manages payments and allows users to schedule rides up to seven days in advance. In addition to its core ride-sharing services, Lyft has expanded into the bike and scooter-sharing markets, providing users with multimodal transportation solutions. The company's primary focus is on serving college, university, and corporate communities.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.